news semaglutide Newspaper headlines: Ozempic 'slows ageing' and Jenas 'battling to save marriage' Searching 'weight' can bring up

Found 12% of US adults currently taking a GLP-1 drug (up from 6% in May 2024)

The advent of glucagon-like peptide-1 receptor agonists (GLP-1RA) has transformed diabetes care, not only through improvements in HbA1c and body weight, but by demonstrating a consistent reduction in major adverse cardiovascular events (MACE)

Heavyweights including Amgen and Pfizer are on the list of aspiring players, as well as smaller companies including Carmot Therapeutics, Structure Therapeutics, Zealand Pharma, Altimmune, Regor Therapeutics, and Vivani Medical

Assess adherence and reasons for stopping

1 Cycles are more likely to be anovulatory compared to previous stages and are underpinned by erratic hormonal patterns

We take a personalized approach to each patient, creating tailored plans that address individual goals and needs